Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib - PubMed
5 hours ago
- #FLT3 mutation
- #gilteritinib efficacy
- #extramedullary AML
- Study focuses on FLT3 mutated extramedullary acute myeloid leukemia (AML).
- Investigates the disease course of this specific AML subtype.
- Assesses the efficacy of the treatment gilteritinib.